Duxin Sun

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 54

Top Topics

Acute Myeloid Leukemia

Radical Prostatectomy

Reactive Oxygen Species

Prostate Cancer

Top Venues

Journal of medicinal chemistry

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Changwei Wang, Mi Wang, Yu Wang, Rohan Kalyan Rej, Angelo Aguilar, Tianfeng Xu, Longchuan Bai, Jelena Tošović, Donna McEachern, Qiuxia Li, Farzad Sarkari, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9. Journal of medicinal chemistry (2024)
Chengyi Li, Ryan Clauson, Luke F Bugada, Fang Ke, Bing He, Zhixin Yu, Hongwei Chen, Binyamin Jacobovitz, Hongxiang Hu, Polina Chuikov, Brett Dallas Hill, Syed M Rizvi, Yudong Song, Kai Sun, Pasieka Axenov, Daniel Huynh, Xinyi Wang, Lana Garmire, Yu Leo Lei, Irina Grigorova, Fei Wen, Marilia Cascalho, Wei Gao, Duxin Sun
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk. ACS nano 18 (13) (2024)
Chengyi Li, Ryan Clauson, Luke F Bugada, Fang Ke, Bing He, Zhixin Yu, Hongwei Chen, Binyamin Jacobovitz, Hongxiang Hu, Polina Chuikov, Brett Dallas Hill, Syed M Rizvi, Yudong Song, Kai Sun, Pasieka Axenov, Daniel Huynh, Xinyi Wang, Lana Garmire, Yu Leo Lei, Irina Grigorova, Fei Wen, Marilia Cascalho, Wei Gao, Duxin Sun
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk. ACS nano 18 (13) (2024)
Albert Cao, Luchen Zhang, Yingzi Bu, Duxin Sun
Machine Learning Prediction of On/Off Target-driven Clinical Adverse Events. Pharmaceutical research 41 (8) (2024)
Chengyi Li, Ryan Clauson, Luke F Bugada, Fang Ke, Bing He, Zhixin Yu, Hongwei Chen, Binyamin Jacobovitz, Hongxiang Hu, Polina Chuikov, Brett Dallas Hill, Syed M Rizvi, Yudong Song, Kai Sun, Pasieka Axenov, Daniel Huynh, Xinyi Wang, Lana Garmire, Yu Leo Lei, Irina Grigorova, Fei Wen, Marilia Cascalho, Wei Gao, Duxin Sun
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk. ACS nano 18 (13) (2024)
Changwei Wang, Mi Wang, Yu Wang, Rohan Kalyan Rej, Angelo Aguilar, Tianfeng Xu, Longchuan Bai, Jelena Tošović, Donna McEachern, Qiuxia Li, Farzad Sarkari, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9. Journal of medicinal chemistry 67 (16) (2024)
Albert Cao, Luchen Zhang, Yingzi Bu, Duxin Sun
Machine Learning Prediction of On/Off Target-driven Clinical Adverse Events. Pharmaceutical research 41 (8) (2024)
Chengyi Li, Ryan Clauson, Luke F Bugada, Fang Ke, Bing He, Zhixin Yu, Hongwei Chen, Binyamin Jacobovitz, Hongxiang Hu, Polina Chuikov, Brett Dallas Hill, Syed M Rizvi, Yudong Song, Kai Sun, Pasieka Axenov, Daniel Huynh, Xinyi Wang, Lana Garmire, Yu Leo Lei, Irina Grigorova, Fei Wen, Marilia Cascalho, Wei Gao, Duxin Sun
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk. ACS nano 18 (13) (2024)
Zhixiang Chen, Mi Wang, Dimin Wu, Longchuan Bai, Tianfeng Xu, Hoda Metwally, Yu Wang, Donna McEachern, Lijie Zhao, Ruiting Li, John Takyi-Williams, Meilin Wang, Lu Wang, Qiuxia Li, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression. Journal of medicinal chemistry 67 (7) (2024)
Chengyi Li, Ryan Clauson, Luke F Bugada, Fang Ke, Bing He, Zhixin Yu, Hongwei Chen, Binyamin Jacobovitz, Hongxiang Hu, Polina Chuikov, Brett Dallas Hill, Syed M Rizvi, Yudong Song, Kai Sun, Pasieka Axenov, Daniel Huynh, Xinyi Wang, Lana Garmire, Yu Leo Lei, Irina Grigorova, Fei Wen, Marilia Cascalho, Wei Gao, Duxin Sun
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk. ACS nano (2024)
Albert Cao, Luchen Zhang, Yingzi Bu, Duxin Sun
Machine Learning Prediction of On/Off Target-driven Clinical Adverse Events. Pharmaceutical research (2024)
Changwei Wang, Mi Wang, Yu Wang, Rohan Kalyan Rej, Angelo Aguilar, Tianfeng Xu, Longchuan Bai, Jelena Tošović, Donna McEachern, Qiuxia Li, Farzad Sarkari, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9. Journal of medicinal chemistry 67 (16) (2024)
Zhixiang Chen, Mi Wang, Dimin Wu, Longchuan Bai, Tianfeng Xu, Hoda Metwally, Yu Wang, Donna McEachern, Lijie Zhao, Ruiting Li, John Takyi-Williams, Meilin Wang, Lu Wang, Qiuxia Li, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression. Journal of medicinal chemistry 67 (7) (2024)
Duxin Sun, Christian Macedonia, Zhigang Chen, Sriram Chandrasekaran, Kayvan Najarian, Simon Zhou, Tim Cernak, Vicki L Ellingrod, H V Jagadish, Bernard Marini, Manjunath Pai, Angela Violi, Jason C Rech, Shaomeng Wang, Yan Li, Brian Athey, Gilbert S Omenn
Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival? Journal of medicinal chemistry (2024)
Zhixiang Chen, Mi Wang, Dimin Wu, Lijie Zhao, Hoda Metwally, Wei Jiang, Yu Wang, Longchuan Bai, Donna McEachern, Jie Luo, Meilin Wang, Qiuxia Li, Aleksas Matvekas, Bo Wen, Duxin Sun, Arul M Chinnaiyan, Shaomeng Wang
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer. Journal of medicinal chemistry 67 (7) (2024)
Chengyi Li, Ryan Clauson, Luke F Bugada, Fang Ke, Bing He, Zhixin Yu, Hongwei Chen, Binyamin Jacobovitz, Hongxiang Hu, Polina Chuikov, Brett Dallas Hill, Syed M Rizvi, Yudong Song, Kai Sun, Pasieka Axenov, Daniel Huynh, Xinyi Wang, Lana Garmire, Yu Leo Lei, Irina Grigorova, Fei Wen, Marilia Cascalho, Wei Gao, Duxin Sun
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk. ACS nano 18 (13) (2024)
Zhixiang Chen, Mi Wang, Dimin Wu, Lijie Zhao, Hoda Metwally, Wei Jiang, Yu Wang, Longchuan Bai, Donna McEachern, Jie Luo, Meilin Wang, Qiuxia Li, Aleksas Matvekas, Bo Wen, Duxin Sun, Arul M Chinnaiyan, Shaomeng Wang
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer. Journal of medicinal chemistry (2024)
Zhixiang Chen, Mi Wang, Dimin Wu, Longchuan Bai, Tianfeng Xu, Hoda Metwally, Yu Wang, Donna McEachern, Lijie Zhao, Ruiting Li, John Takyi-Williams, Meilin Wang, Lu Wang, Qiuxia Li, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression. Journal of medicinal chemistry (2024)
Zhixiang Chen, Mi Wang, Dimin Wu, Lijie Zhao, Hoda Metwally, Wei Jiang, Yu Wang, Longchuan Bai, Donna McEachern, Jie Luo, Meilin Wang, Qiuxia Li, Aleksas Matvekas, Bo Wen, Duxin Sun, Arul M Chinnaiyan, Shaomeng Wang
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer. Journal of medicinal chemistry 67 (7) (2024)
Abbie D Leino, John Takyi-Williams, Jeong Mi Park, Silas P Norman, Duxin Sun, Karen B Farris, Manjunath Amit P Pai
Clinical validation of two volumetric absorptive microsampling devices to support home-based therapeutic drug monitoring of immunosuppression. British journal of clinical pharmacology (2024)
Atsunori Kaneshige, Longchuan Bai, Mi Wang, Donna McEachern, Jennifer L Meagher, Renqi Xu, Yu Wang, Wei Jiang, Hoda Metwally, Paul D Kirchhoff, Lijie Zhao, Hui Jiang, Meilin Wang, Bo Wen, Duxin Sun, Jeanne A Stuckey, Shaomeng Wang
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo. Nature chemical biology (2023)
Xinrui Yuan, Hua Jiang, Denggang Fu, Jason C Rech, Aaron Robida, Krishani Rajanayake, Hebao Yuan, Miao He, Bo Wen, Duxin Sun, Chen Liu, Krishnapriya Chinnaswamy, Jeanne A Stuckey, Sophie Paczesny, Chao-Yie Yang
Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors. ACS pharmacology & translational science 6 (9) (2023)
Yingzi Bu, Ruoxi Gao, Bohan Zhang, Luchen Zhang, Duxin Sun
CoGT: Ensemble Machine Learning Method and Its Application on JAK Inhibitor Discovery. ACS omega 8 (14) (2023)
Atsunori Kaneshige, Longchuan Bai, Mi Wang, Donna McEachern, Jennifer L Meagher, Renqi Xu, Paul D Kirchhoff, Bo Wen, Duxin Sun, Jeanne A Stuckey, Shaomeng Wang
Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia. Journal of medicinal chemistry 66 (4) (2023)
Junius Eugene Thomas, Mi Wang, Wei Jiang, Meilin Wang, Lu Wang, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of Exceptionally Potent, Selective, and Efficacious PROTAC Degraders of CBP and p300 Proteins. Journal of medicinal chemistry (2023)
Atsunori Kaneshige, Longchuan Bai, Mi Wang, Donna McEachern, Jennifer L Meagher, Renqi Xu, Paul D Kirchhoff, Bo Wen, Duxin Sun, Jeanne A Stuckey, Shaomeng Wang
Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia. Journal of medicinal chemistry (2023)
Xin Han, Lijie Zhao, Weiguo Xiang, Bukeyan Miao, Chong Qin, Mi Wang, Tianfeng Xu, Donna McEachern, Jianfeng Lu, Yu Wang, Hoda Metwally, Chao-Yie Yang, Paul D Kirchhoff, Lu Wang, Aleksas Matvekas, John Takyi-Williams, Bo Wen, Duxin Sun, Mark Ator, Robert Mckean, Shaomeng Wang
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer. Journal of medicinal chemistry (2023)
Zhixiang Chen, Biao Hu, Rohan Kalyan Rej, Dimin Wu, Ranjan Kumar Acharyya, Mingliang Wang, Tianfeng Xu, Jianfeng Lu, Hoda Metwally, Yu Wang, Donna McEachern, Longchuan Bai, Christina L Gersch, Meilin Wang, Wenjing Zhang, Qiuxia Li, Bo Wen, Duxin Sun, James M Rae, Shaomeng Wang
Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity. Journal of medicinal chemistry (2023)
Atsunori Kaneshige, Longchuan Bai, Mi Wang, Donna McEachern, Jennifer L Meagher, Renqi Xu, Paul D Kirchhoff, Bo Wen, Duxin Sun, Jeanne A Stuckey, Shaomeng Wang
Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia. Journal of medicinal chemistry 66 (4) (2023)
Lin Yang, Wenbin Tu, Liyue Huang, Bukeyan Miao, Atsunori Kaneshige, Wei Jiang, Lingying Leng, Meilin Wang, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor Activity. Journal of medicinal chemistry (2023)
Joyeeta Roy, Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi-Williams, Duxin Sun, Essam Eldin A Osman, Nouri Neamati
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry (2023)
John Takyi-Williams, Abbie D Leino, Ruiting Li, Kevin James Downes, Athena F Zuppa, Amanda Bwint, Bo Wen, Duxin Sun, Marc H Scheetz, Manjunath Amit P Pai
Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill children. Bioanalysis (2023)
Atsunori Kaneshige, Longchuan Bai, Mi Wang, Donna McEachern, Jennifer L Meagher, Renqi Xu, Paul D Kirchhoff, Bo Wen, Duxin Sun, Jeanne A Stuckey, Shaomeng Wang
Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia. Journal of medicinal chemistry 66 (4) (2023)
Joyeeta Roy, Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi-Williams, Duxin Sun, Essam Eldin A Osman, Nouri Neamati
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 66 (3) (2023)
Weiguo Xiang, Lijie Zhao, Xin Han, Tianfeng Xu, Steven Kregel, Mi Wang, Bukeyan Miao, Chong Qin, Mingliang Wang, Donna McEachern, Jianfeng Lu, Longchuan Bai, Chao-Yie Yang, Paul D Kirchhoff, John Takyi-Williams, Lu Wang, Bo Wen, Duxin Sun, Mark Ator, Robert Mckean, Arul M Chinnaiyan, Shaomeng Wang
Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer. Journal of medicinal chemistry (2023)
Joyeeta Roy, Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi-Williams, Duxin Sun, Essam Eldin A Osman, Nouri Neamati
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 66 (3) (2023)
Joyeeta Roy, Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi-Williams, Duxin Sun, Essam Eldin A Osman, Nouri Neamati
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 66 (3) (2023)
Ding Xue, Yibin Xu, Armita Kyani, Joyeeta Roy, Lipeng Dai, Duxin Sun, Nouri Neamati
Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 65 (4) (2022)
Abbie D Leino, John Takyi-Williams, Bo Wen, Duxin Sun, Manjunath Amit P Pai
Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppression. Bioanalysis 14 (17) (2022)
Hongxiang Hu, Mohamed Dit Mady Traore, Ruiting Li, Hebao Yuan, Miao He, Bo Wen, Wei Gao, Colleen Beth Jonsson, Elizabeth A Fitzpatrick, Duxin Sun
Optimization of the Prodrug Moiety of Remdesivir to Improve Lung Exposure/Selectivity and Enhance Anti-SARS-CoV-2 Activity. Journal of medicinal chemistry 65 (18) (2022)
Ding Xue, Yibin Xu, Armita Kyani, Joyeeta Roy, Lipeng Dai, Duxin Sun, Nouri Neamati
Discovery and Lead Optimization of Benzene-1,4-disulfonamides as Oxidative Phosphorylation Inhibitors. Journal of medicinal chemistry 65 (1) (2022)
Yudong Song, Luke Bugada, Ruiting Li, Hongxiang Hu, Luchen Zhang, Chengyi Li, Hebao Yuan, Krishani Kumari Rajanayake, Nathan A Truchan, Fei Wen, Wei Gao, Duxin Sun
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice. Science translational medicine 14 (643) (2022)
Kai Wang, Yangbing Li, Bing Chen, Hao Chen, David E Smith, Duxin Sun, Meihua R Feng, Gordon L Amidon
In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil. Molecular pharmaceutics 19 (7) (2022)
Xin Han, Lijie Zhao, Weiguo Xiang, Chong Qin, Bukeyan Miao, Donna McEachern, Yu Wang, Hoda Metwally, Lu Wang, Aleksas Matvekas, Bo Wen, Duxin Sun, Shaomeng Wang
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer. Journal of medicinal chemistry 64 (17) (2021)
Haibin Zhou, Longchuan Bai, Renqi Xu, Donna McEachern, Krishnapriya Chinnaswamy, Ruiting Li, Bo Wen, Mi Wang, Chao-Yie Yang, Jennifer L Meagher, Duxin Sun, Jeanne A Stuckey, Shaomeng Wang
SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression. ACS medicinal chemistry letters 12 (6) (2021)
Weiguo Xiang, Lijie Zhao, Xin Han, Chong Qin, Bukeyan Miao, Donna McEachern, Yu Wang, Hoda Metwally, Paul D Kirchhoff, Lu Wang, Aleksas Matvekas, Miao He, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer. Journal of medicinal chemistry 64 (18) (2021)
Oren Rom, Yuhao Liu, Zhipeng Liu, Ying Zhao, Jianfeng Wu, Alia Ghrayeb, Luis Villacorta, Yanbo Fan, Lin Chang, Lu Wang, Cai Liu, Dongshan Yang, Jun Song, Jason C Rech, Yanhong Guo, Huilun Wang, Guizhen Zhao, Wenying Liang, Ying Yu, Haocheng Lu, Tomonari Koike, Tony Hayek, Subramaniam Pennathur, Chuanwu Xi, Bo Wen, Duxin Sun, Minerva T Garcia-Barrio, Michael Aviram, Eyal Gottlieb, Inbal Mor, Wanqing Liu, Jifeng Zhang, Yuqing Eugene Chen
Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome. Science translational medicine 12 (572) (2021)
Rohan Kalyan Rej, Changwei Wang, Jianfeng Lu, Mi Wang, Elyse Petrunak, Kaitlin P Zawacki, Donna McEachern, Chao-Yie Yang, Lu Wang, Ruiting Li, Krishnapriya Chinnaswamy, Bo Wen, Duxin Sun, Jeanne A Stuckey, Yunlong Zhou, Jianyong Chen, Guozhi Tang, Shaomeng Wang
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression. Journal of medicinal chemistry 64 (19) (2021)
Rohan Kalyan Rej, Changwei Wang, Jianfeng Lu, Mi Wang, Elyse Petrunak, Kaitlin P Zawacki, Donna McEachern, Ester Fernandez-Salas, Chao-Yie Yang, Lu Wang, Ruiting Li, Krishnapriya Chinnaswamy, Bo Wen, Duxin Sun, Jeanne Stuckey, Yunlong Zhou, Jianyong Chen, Guozhi Tang, Shaomeng Wang
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm Development. Journal of medicinal chemistry 63 (13) (2020)
Yan Li, Maria Palmisano, Duxin Sun, Simon Zhou
Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies. Clinical pharmacology : advances and applications 12 (2020)
Hebao Yuan, Hongwei Guo, Xin Luan, Miao He, Feng Li, Joseph Burnett, Nathan Truchan, Duxin Sun
Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer. Molecular pharmaceutics 17 (7) (2020)
Shuai Hu, Mario Sechi, Pankaj Kumar Singh, Lipeng Dai, Sean McCann, Duxin Sun, Mats Ljungman, Nouri Neamati
A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species. Journal of medicinal chemistry 63 (17) (2020)
Michael W Wilson, Liming Shu, Vania Hinkovska-Galcheva, Yafei Jin, Walajapet Rajeswaran, Akira Abe, Ting Zhao, Ruijuan Luo, Lu Wang, Bo Wen, Benjamin Liou, Venette Fannin, Duxin Sun, Ying Sun, James A Shayman, Scott D Larsen
Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3. ACS chemical neuroscience 11 (20) (2020)
Duxin Sun, Simon Zhou, Wei Gao
What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right. ACS nano 14 (10) (2020)